menu
    • menu

    Company profile for Elutia

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Elutia develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. Elutia offers a proprietary drug-eluting biologic technology: a fusion of natural biologic material and extended antibiotic release, perfected for device implantation and soft tissue reconstruction. Our offerings, CanGaroo for implantable electronic devices and SimpliDerm for soft-tissue reconst...
    Elutia develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. Elutia offers a proprietary drug-eluting biologic technology: a fusion of natural biologic material and extended antibiotic release, perfected for device implantation and soft tissue reconstruction. Our offerings, CanGaroo for implantable electronic devices and SimpliDerm for soft-tissue reconstruction, provide robust, but easy-to-use constructs that ensure implant stability and promote wound healing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ElutiaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12510 Prosperity Drive, Suite 370 Silver Spring, MD 20904
    Telephone
    Telephone
    +1 2402471170
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://elutia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Elutia Strengthens Financials And Previews NXT-41X Progress
    Elutia Strengthens Financials And Previews NXT-41X Progress

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216845/0/en/Elutia-Reports-Preliminary-Fourth-Quarter-2025-Results-Strengthened-Financial-Position-and-Upcoming-NXT-41x-Milestones.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Elutia Presents NXT-41x at the Global Bio-Innovation Forum
    Elutia Presents NXT-41x at the Global Bio-Innovation Forum

    10 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216047/0/en/Elutia-to-Present-at-Global-BioInnovation-Forum-on-NXT-41x-Biomatrix-Program-for-Plastic-and-Reconstructive-Surgery.html

    GLOBENEWSWIRE
    10 Jan 2026
    Share Share
    Elutia Reports Third Quarter 2025 Financial Results
    Elutia Reports Third Quarter 2025 Financial Results

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183112/0/en/Elutia-Reports-Third-Quarter-2025-Financial-Results-Closes-88-Million-Sale-of-BioEnvelope-Business-to-Boston-Scientific-Corporation-Funds-NXT-41x-Development.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Elutia To Release Q3 2025 Financial Results On November 6
    Elutia To Release Q3 2025 Financial Results On November 6

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172436/0/en/Elutia-to-Report-Third-Quarter-2025-Financial-Results-on-Thursday-November-6-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Elutia To Present At LD Micro Main Event XIX Conference
    Elutia To Present At LD Micro Main Event XIX Conference

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166645/0/en/Elutia-to-Present-at-the-LD-Micro-Main-Event-XIX-Conference-on-Tuesday-October-21.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Elutia Appoints Medtech Veteran Guido J. Neels To Directors Board
    Elutia Appoints Medtech Veteran Guido J. Neels To Directors Board

    10 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/10/3164813/0/en/Elutia-Appoints-Accomplished-MedTech-Veteran-Guido-J-Neels-to-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search